耳部与非耳部瘢痕疙瘩切除后结局的区域差异
该回顾性队列研究分析168例瘢痕疙瘩(耳部60例、非耳部108例),比较手术切除联合辅助放疗或单纯手术后的复发率及放疗副作用。结果显示解剖部位不影响复发率,辅助放疗显著降低复发,非耳部部位放疗相关副作用更常见。
要点
- 耳部与非耳部瘢痕疙瘩切除后复发率无显著差异。
- 辅助放疗可显著降低瘢痕疙瘩复发率,不受部位影响。
- 非耳部部位放疗相关副作用发生率显著高于耳部。
核心结论
- 解剖部位未显著影响瘢痕疙瘩复发率,挑战了既往关于部位特异性治疗反应的假设。
- 辅助放疗无论部位如何均显著降低复发率。
- 放疗相关副作用在非耳部部位更常见。
研究设计与样本
- 回顾性队列研究,分析168例瘢痕疙瘩病例(耳部60例,非耳部108例),由单一外科医生于2020年1月至2024年5月治疗。
- 122例接受手术切除联合辅助放疗,46例接受单纯手术切除;两组均在切除时注射5-氟尿嘧啶和Kenalog。
主要发现
- 耳部瘢痕疙瘩更常见于年轻患者,且尺寸显著更小(中位数12 mm vs 非耳部19.5 mm,P <0.001)。
- 手术联合放疗组中,耳部复发率17.07%,非耳部16.22%(P =0.91)。
- 单纯手术组中,耳部复发率47.37%,非耳部44.12%(P =0.82)。
- 放疗相关副作用在非耳部部位发生率为37%,显著高于耳部的20%(P =0.022)。
- 年龄、性别、种族、BMI及放疗剂量在最终模型中未独立预测复发。
关键数值与推荐
- 多数患者接受2100 cGy放疗剂量。
- 手术联合放疗组复发率耳部17.07%、非耳部16.22%(P =0.91);单纯手术组耳部47.37%、非耳部44.12%(P =0.82)。
- 放疗相关副作用非耳部37% vs 耳部20%(P =0.022)。
临床怎么用
- 支持在瘢痕疙瘩管理中常规纳入放疗以降低复发。
- 非耳部部位放疗时需更关注副作用监测。
- 人口学因素和治疗因素可能比解剖部位更能预测结局。
局限性
- 回顾性研究设计。
- 单外科医生操作,可能存在选择偏倚。
- 未报告随访时长及失访情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The pathophysiology of keloid formation remains poorly understood, and treatment typically involves multimodal approaches. Previous studies suggest that keloids on the earlobes, head, and neck may be more responsive to radiation than those on other anatomic sites due to putative differences in skin tension and biomechanical properties. However, limited comparative data exist to substantiate these anatomic distinctions in clinical outcomes. AIM: To compare recurrence rates, treatment outcomes, and radiation-related side effects between auricular and nonauricular keloids following surgical excision with adjuvant radiation therapy or surgical excision alone. METHODS: This retrospective cohort study analysed 168 cases with keloids (60 auricular and 108 nonauricular) treated by a single surgeon between January 2020 and May 2024. Of these, 122 patients underwent surgical excision followed by adjuvant radiation therapy, while 46 patients received surgical excision only. Intralesional 5-Fluorouracil and Kenalog was injected across both groups during surgical excision. Demographic and clinical data, including age, sex, race, BMI, keloid site and size, and treatment modality, were collected. Patients were followed up post-treatment to assess recurrence, radiation-related side effects, and treatment response patterns. RESULTS: Auricular keloids were more common in younger patients and significantly smaller in size (median 12 vs. 19.5 mm for nonauricular, P <0.001). The majority of patients received 2100 cGy of radiation. Among those receiving surgery plus radiation, 17.07% of auricular and 16.22% of nonauricular keloids recurred ( P =0.91). In the surgery-only group, recurrence was 47.37% and 44.12%, respectively ( P =0.82). Notably, radiation-related side effects were significantly more frequent in nonauricular sites (37%) compared with auricular (20%) ( P =0.022). Age, sex, race, BMI, and radiation dose did not independently predict recurrence in the final model. CONCLUSION: Anatomic site did not significantly influence keloid recurrence rates, challenging previous assumptions about site-specific treatment responses, while adjuvant radiotherapy significantly reduced recurrence irrespective of site. Radiation-related side effects were more common in nonauricular locations. Age, sex, race and BMI did not emerge as statistically significant demographic predictors of recurrence in this study. These findings support the routine inclusion of radiotherapy in keloid management and suggest that demographic and treatment factors may outweigh anatomic considerations in predicting outcomes.
引用
- Kumar SIS, Katta T, Anderson M, et al. Regional Differences in Postexcision Outcomes of Keloids: A Focus on Auricular Versus Nonauricular Sites. Ann Plast Surg. 2026. PMID: 42184131. doi:10.1097/SAP.0000000000004775
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。